Suven Pharmaceuticals Ltd. - Research Center

---

Results

• Quarterly
• Half yearly
• Annual

Statement

• Balance sheet
• P&L
• Cash flow

More

• Dividend
• Bonus
• Share holding
• Capital structures
• Ratio

Mar ' 24	Mar ' 23	Mar ' 22	Mar ' 21	Mar ' 20

Sales

1,024.99

1,330.08

1,320.22

1,009.72

833.79

Operating profit

409.90

583.08

579.99

440.52

385.15

Interest

7.43

5.39

6.23

9.14

21.81

Gross profit

457.57

622.24

761.55

445.62

381.45

EPS (Rs)

11.97

16.99

21.92

12.12

21.22

Other income

55.09

44.55

187.79

14.24

18.12

Stock adjustment

53.88

-20.94

-60.35

-8.37

-11.05

Raw material

248.38

421.36

459.46

310.32

240.24

Power and fuel

-

-

-

-

-

Employee expenses

126.88

100.84

100.48

76.23

73.72

Excise

-

-

-

-

-

Admin and selling expenses

-

-

-

-

-

Research and development expenses

-

8.59

10.35

11.06

-

Expenses capitalised

-

-

-

-

-

Other expenses

185.95

237.16

230.29

179.96

145.73

Provisions made

-

-

-

-

-

Depreciation

48.79

42.84

39.10

31.64

23.86

Taxation

103.96

146.79

164.35

105.33

87.51

Net profit / loss

304.82

432.60

558.10

308.65

270.08

Extra ordinary item

-

-

-

-

-

Prior year adjustments

-

-

-

-

-

Equity capital

25.46

25.46

25.46

25.46

12.73

Equity dividend rate

-

-

-

-

-

Agg.of non-prom. shares (Lacs)

-

-

-

-

-

Agg.of non promotoholding (%)

-

-

-

-

-

OPM (%)

39.99

43.84

43.93

43.63

46.19

GPM (%)

42.36

45.27

50.50

43.52

44.78

NPM (%)

28.22

31.47

37.01

30.14

31.70